beta-cells
发表于 2025-3-25 04:43:34
Clinical Testing of a New Drug,development plan and new regulatory approval pathways. We offer some examples of recent advancements in clinical trial designs and conclude the chapter with a short summary of the salient points covered in the chapter.
凶残
发表于 2025-3-25 08:21:52
http://reply.papertrans.cn/79/7809/780823/780823_22.png
PHON
发表于 2025-3-25 14:13:12
http://reply.papertrans.cn/79/7809/780823/780823_23.png
jumble
发表于 2025-3-25 18:39:17
http://reply.papertrans.cn/79/7809/780823/780823_24.png
Spirometry
发表于 2025-3-25 23:28:28
http://reply.papertrans.cn/79/7809/780823/780823_25.png
MOT
发表于 2025-3-26 00:22:28
http://reply.papertrans.cn/79/7809/780823/780823_26.png
esculent
发表于 2025-3-26 07:10:33
A Frequentist Decision-Making Framework,ons under the Frequentist approach are calibrated by how they would perform when they are used repeatedly. In the context of drug development, the two actions correspond to progressing or not progressing a drug for further development. These two actions are fundamental to decision-making in drug development.
引起
发表于 2025-3-26 09:33:53
Characteristics of a Diagnostic Test,ew the metrics commonly used to characterize the performance of a diagnostic test. We then discuss what it means when a diagnostic test returns a positive or a negative result. We illustrate the discussions with the use of several decision rules.
文字
发表于 2025-3-26 15:54:54
Book 20171st editionical industry who have a basic understanding of the drug-development processand the clinical trials conducted to support drug-marketing authorization.. .The authors provide software codes for select analytical approaches discussed in the book. The book includes enough technical details to allow stat
冷淡一切
发表于 2025-3-26 18:37:13
http://reply.papertrans.cn/79/7809/780823/780823_30.png